AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
69.11
-0.17 (-0.25%)
May 6, 2026, 1:07 PM EDT - Market open
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.99 billion as of May 6, 2026. Its market cap has increased by 214.22% in one year.
Market Cap
1.99B
Enterprise Value
1.91B
1-Year Change
214.22%
Ranking
Category
Stock Price
$69.11
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.99B, an increase of 543.60%. That is a compound annual growth rate of 22.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 1.99B | 48.38% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 2.13B |
| Ocular Therapeutix | 2.13B |
| Tyra Biosciences | 2.09B |
| Aurinia Pharmaceuticals | 2.05B |
| Mesoblast | 2.04B |
| Ascentage Pharma Group International | 2.04B |
| Trevi Therapeutics | 2.02B |
| Zymeworks | 1.98B |